Nuveen’s Eli Lilly LLY Stock Holding History

Nuveen’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,300	Closed	-$3K	–	3385
2022 Q1	$3K	Buy	+10,300	New	+$2.65M	﹤0.01%	3361
2021 Q2	–	Sell	-25,700	Closed	-$5K	–	3461
2021 Q1	$5K	Buy	+25,700	New	+$5.03M	﹤0.01%	3330

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen's LLY Position: Q2 2026 in Review

Nuveen reduced its Eli Lilly (LLY) stake by 5.2% in Q2 2026, selling an estimated $282M and leaving 5,061,510 shares worth $6.07B. The position accounts for 1.45% of the portfolio, ranked #9.

Nuveen first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,641 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Nuveen held 5,061,510 shares of Eli Lilly worth $6.07B as of Q2 2026.
Nuveen sold 276,162 Eli Lilly shares in Q2 2026, an estimated $282M.
Eli Lilly made up 1.45% of Nuveen's portfolio in Q2 2026, its #9 holding.
Nuveen first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
4,641 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.